头孢哌酮-舒巴坦治疗24例肾盂肾炎的临床疗效观察

摘要

Objective:To observe the clinical efficacy of Sulbactam and Cefopcrazone,Cefperazone-Sulbactam in the treatment of pyelonephritis. Method:48 cases of pyelonephritis patients in our hospital were randomly divided into two groups,control group was treated with Levofloxacin,the treatment group were treated with Sulbactam and Cefopcrazone,Cefperazone-Sulbactam,the treatment effect and the adverse reaction in two groups were compared.Result:After one course of treatment,the total efficiency of the treatment group was significantly higher than that in the control group(P<0.05),the recurrence rate of the treatment group in 6 months was lower than that in the control group(P<0.05),the adverse reaction in two groups had no significantly difference(P>0.05).Conclusion:Sulbactam and Cefopcrazone,Cefperazone-Sulbactam in the treatment of pyelonephritis is significant efficacy,and safety,and is an ideal drug treatment of pyelonephritis.%目的：观察头孢哌酮-舒巴坦治疗肾盂肾炎的临床疗效。方法：将笔者所在医院收治的48例肾盂肾炎患者随机分为两组：对照组应用左氧氟沙星治疗，治疗组应用头孢哌酮-舒巴坦治疗，对比两组患者的治疗效果、不良反应情况。结果：治疗1个疗程后，治疗组的总有效率显著高于对照组(P<0.05)；治疗组在治疗后6个月内的复发率明显低于对照组(P<0.05)。两组不良反应比较差异无统计学意义(P>0.05)。结论：对肾盂肾炎患者应用头孢哌酮-舒巴坦治疗，具有显著疗效，且安全性好，是治疗肾盂肾炎的理想药物。